Literature DB >> 28674966

Preoperative staging of endometrial cancer using reduced field-of-view diffusion-weighted imaging: a preliminary study.

Takashi Ota1, Masatoshi Hori2, Hiromitsu Onishi1, Makoto Sakane1, Takahiro Tsuboyama1, Mitsuaki Tatsumi1, Atsushi Nakamoto3, Tadashi Kimura4, Yoshifumi Narumi3, Noriyuki Tomiyama1.   

Abstract

OBJECTIVES: To compare the image quality and diagnostic performance of reduced field-of-view (rFOV) versus conventional full field-of-view (fFOV) diffusion-weighted (DW) imaging of endometrial cancer.
METHODS: Fifty women with endometrial cancer underwent preoperative rFOV and fFOV DW imaging. Two radiologists compared the image qualities of both techniques, and five radiologists assessed superficial and deep myometrial invasion using both techniques. The statistical analysis included the Wilcoxon signed-rank test and paired t-test for comparisons of image quality and mean diagnostic values.
RESULTS: Distortion, tumour delineation, and overall image quality were significantly better with rFOV DW imaging, compared to fFOV DW imaging (P < 0.05); however, the former was inferior in noise (P < 0.05). Regarding superficial invasion, the mean accuracies of the techniques did not differ statistically (rFOV, 58.0% versus fFOV, 56.0%; P = 0.30). Regarding deep myometrial invasion, rFOV DW imaging yielded significantly better mean accuracy, specificity, and positive predictive values (88.4%, 97.8%, and 91.7%, respectively), compared with fFOV DW imaging (84.8%, 94.1%, and 77.4%, respectively; P = 0.009, 0.005, and 0.011, respectively).
CONCLUSIONS: Compared with fFOV DW imaging, rFOV DW imaging yielded less distortion, improved image quality and, consequently, better diagnostic performance for deep myometrial invasion of endometrial cancer. KEY POINTS: • rFOV DWI yields better assessment of deep myometrial invasion in endometrial cancer. • rFOV DWI could not sufficiently evaluate superficial invasion in endometrial cancer. • Distortion, tumour delineation, and overall image quality were improved with rFOV DWI.

Entities:  

Keywords:  Diffusion-weighted; Endometrial neoplasms; Magnetic resonance imaging; Neoplasm staging; Uterine neoplasms

Mesh:

Year:  2017        PMID: 28674966     DOI: 10.1007/s00330-017-4922-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  28 in total

1.  Influence of menopausal status on diagnostic accuracy of myometrial invasion in endometrial cancer: diffusion-weighted and dynamic contrast-enhanced MRI at 3 T.

Authors:  G Lin; Y-T Huang; A Chao; K-K Ng; L-Y Yang; S-H Ng; C-H Lai
Journal:  Clin Radiol       Date:  2015-07-29       Impact factor: 2.350

2.  Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.

Authors:  Gigin Lin; Koon-Kwan Ng; Chee-Jen Chang; Jiun-Jie Wang; Kung-Chu Ho; Tzu-Chen Yen; Tzu-I Wu; Chun-Chieh Wang; Yu-Ruei Chen; Yu-Ting Huang; Shu-Hang Ng; Shih-Ming Jung; Ting-Chang Chang; Chyong-Huey Lai
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

3.  High resolution diffusion weighted magnetic resonance imaging of the pancreas using reduced field of view single-shot echo-planar imaging at 3 T.

Authors:  Chao Ma; Yan-jun Li; Chun-shu Pan; He Wang; Jian Wang; Shi-yue Chen; Jian-ping Lu
Journal:  Magn Reson Imaging       Date:  2013-10-18       Impact factor: 2.546

4.  Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer.

Authors:  Priya Bhosale; Jingfei Ma; Revathy Iyer; Preetha Ramalingam; Wei Wei; Pamela Soliman; Michael Frumovitz; Vikas Kundra
Journal:  J Magn Reson Imaging       Date:  2015-07-16       Impact factor: 4.813

5.  Assessment of depth of myometrial invasion in endometrial adenocarcinoma.

Authors:  B A Goff; L W Rice
Journal:  Gynecol Oncol       Date:  1990-07       Impact factor: 5.482

6.  Fertility-preserving treatment in young patients with endometrial adenocarcinoma.

Authors:  Chen-Bin Wang; Chin-Jung Wang; Huei-Jean Huang; Swei Hsueh; Hung-Hsueh Chou; Yung-Kuei Soong; Chyong-Huey Lai
Journal:  Cancer       Date:  2002-04-15       Impact factor: 6.860

7.  Reduced field-of-view diffusion imaging of the human spinal cord: comparison with conventional single-shot echo-planar imaging.

Authors:  G Zaharchuk; E U Saritas; J B Andre; C T Chin; J Rosenberg; T J Brosnan; A Shankaranarayan; D G Nishimura; N J Fischbein
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-31       Impact factor: 3.825

8.  Endometrial cancer: utility of diffusion-weighted magnetic resonance imaging with background body signal suppression at 3T.

Authors:  Jung Min Seo; Chan Kyo Kim; Dongil Choi; Byung Kwan Park
Journal:  J Magn Reson Imaging       Date:  2012-11-13       Impact factor: 4.813

9.  Reduced-FOV excitation decreases susceptibility artifact in diffusion-weighted MRI with endorectal coil for prostate cancer detection.

Authors:  Natalie Korn; John Kurhanewicz; Suchandrima Banerjee; Olga Starobinets; Emine Saritas; Susan Noworolski
Journal:  Magn Reson Imaging       Date:  2014-09-06       Impact factor: 2.546

10.  Reduced Field-of-View Diffusion-Weighted Magnetic Resonance Imaging of the Pancreas: Comparison with Conventional Single-Shot Echo-Planar Imaging.

Authors:  Hyungjin Kim; Jeong Min Lee; Jeong Hee Yoon; Jin-Young Jang; Sun-Whe Kim; Ji Kon Ryu; Stephan Kannengiesser; Joon Koo Han; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2015-10-26       Impact factor: 3.500

View more
  7 in total

1.  ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

Authors:  Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2021-02       Impact factor: 4.064

2.  Quantitative T2*-Weighted Imaging and Reduced Field-of-View Diffusion-Weighted Imaging of Rectal Cancer: Correlation of R2* and Apparent Diffusion Coefficient With Histopathological Prognostic Factors.

Authors:  Yang Peng; Yan Luo; Xuemei Hu; Yaqi Shen; Daoyu Hu; Zhen Li; Ihab Kamel
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

Review 3.  Current Status of Magnetic Resonance Imaging in Patients with Malignant Uterine Neoplasms: A Review.

Authors:  Yu-Ting Huang; Yen-Ling Huang; Koon-Kwan Ng; Gigin Lin
Journal:  Korean J Radiol       Date:  2018-12-27       Impact factor: 3.500

4.  Histological grades of rectal cancer: whole-volume histogram analysis of apparent diffusion coefficient based on reduced field-of-view diffusion-weighted imaging.

Authors:  Yang Peng; Hao Tang; Xiaoyan Meng; Yaqi Shen; Daoyu Hu; Ihab Kamel; Zhen Li
Journal:  Quant Imaging Med Surg       Date:  2020-01

5.  Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI.

Authors:  Lisa C Adams; Bernhard Ralla; Yi-Na Y Bender; Keno Bressem; Bernd Hamm; Jonas Busch; Florian Fuller; Marcus R Makowski
Journal:  Cancer Imaging       Date:  2018-05-03       Impact factor: 3.909

6.  Qualitative and quantitative comparison of image quality between single-shot echo-planar and interleaved multi-shot echo-planar diffusion-weighted imaging in female pelvis.

Authors:  He An; Xiaodong Ma; Ziyi Pan; Hua Guo; Elaine Yuen Phin Lee
Journal:  Eur Radiol       Date:  2019-12-10       Impact factor: 5.315

7.  Reduced field-of-view diffusion-weighted imaging (DWI) in patients with gastric cancer: Comparison with conventional DWI techniques at 3.0T: A preliminary study.

Authors:  Jin-Song Cai; Hai-Yan Chen; Jie-Yu Chen; Yuan-Fei Lu; Jian-Zhong Sun; Ying Zhou; Ri-Sheng Yu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.